Neurological biologics require scalable cell culture, purification, clean utilities and GMP-ready facilities for reliable commercial production at global scale.
An unusual increase in caustic solution consumption was detected at a CIP station. Thanks to historical data in Track Advance® and Boccard’s process expertise, the source of the deviation was identified and its impact quantified; the avoided excess consumption was estimated at 255 m³/year.
As demand for immunoglobulin therapies grows across rare autoimmune diseases, manufacturers must expand plasma fractionation capacity while maintaining strict GMP and viral safety standards. This case study shows how Boccard delivered a large-scale, integrated immunoglobulin production facility designed to support long-term IVIg supply.
Modern process solutions enable the safe, efficient, and GMP-compliant production of oncology drugs. Thanks to advanced pharmaceutical technologies, it is possible to scale up production while maintaining the highest quality and full process control.
As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.
As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.
As demand for GLP‑1 therapies grows in obesity and Type 2 diabetes care, manufacturers must rapidly scale production while meeting strict GMP requirements. This case study shows how Boccard delivered a robust and scalable GLP‑1 production line.
Discover how lactic acid for food ingredients (E270) is produced by fermenting molasses with lactic‑acid‑producing microorganisms, then readied for scale with inline pH and DO, CIP/SIP and hygienic utilities in a compact footprint. TEKINBIO™ with Track Advance delivers optimised aeration, mixing and thermal control with recipe governance and lot‑to‑lot comparison, creating a reproducible and traceable path to industrialisation.
Discover how E. coli recombinant protein fermentation scale up moves from 5 L glass to a 30 L seed and 150 L main bioreactor, with inline pH/DO/glucose analytics, CIP/SIP and compact centrifuge, sonication and ultrafiltration. A temperature and pH controlled waste inactivation tank enables safe discharge in a limited space. With TEKINBIO™ and Track Advance, teams gain tighter control and traceable scale‑up for reliable industrialisation.
Discover how cosmetic biocarriers are produced through fermentation: combining biosurfactant inputs with biopolymer matrices to encapsulate actives and deliver controlled release. Boccard supplied 2×300 L pilot bioreactors as plug‑and‑connect skids (gas handling, dosing, CIP/SIP), creating a reproducible pilot environment that simplifies recipe iteration and scale‑up. With TEKINBIO™ and Track Advance, teams gain tighter control of aeration, mixing, and temperature, plus lot‑to‑lot comparison for reliable industrialisation.
Nous serons heureux de répondre à vos demandes concernant nos offres marchés, solutions ou services. Pour nous aider à mieux vous répondre, merci de préciser votre besoin : devis, projet, services, demande de contact ou autre.
